# Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study

> **NCT05027698** · — · COMPLETED · sponsor: **Terumo Europe N.V.** · enrollment: 230 (actual)

## Conditions studied

- Vascular Closure
- Endovascular Procedure
- Hemostasis
- Peripheral Vascular Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05027698
- **Lead sponsor:** Terumo Europe N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-27
- **Primary completion:** 2022-07-04
- **Final completion:** 2022-08-03
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2022-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05027698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05027698, "Post-Market Clinical Investigation of the FemoSeal™ VCS: A Prospective, Multi-Center Observational European Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05027698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*